STUDIES ON POTENTIALLY ANTI-TUMOUR ACTIVE STEROID NITROGEN MUSTARDS - MEDI

被引：0
作者：
JONES, JB
LEMAN, JD
机构：
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1970年
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：8 / +
页数：1
相关论文
共 50 条
  • [31] The synthesis of Pt-191 labelled JM216, an orally active platinum anti-tumour agent
    Bates, PI
    Sharma, HL
    Murrer, BA
    Bernard, CFJ
    McAuliffe, CA
    APPLIED RADIATION AND ISOTOPES, 1997, 48 (04) : 469 - 476
  • [32] Secukinumab after anti-tumour necrosis factor- therapy: a phase III study in active rheumatoid arthritis
    Dokoupilova, E.
    Aelion, J.
    Takeuchi, T.
    Malavolta, N.
    Sfikakis, P. P.
    Wang, Y.
    Rohrer, S.
    Richards, H. B.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (04) : 276 - 281
  • [33] The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis
    Drevs, J.
    Schneider, V.
    JOURNAL OF INTERNAL MEDICINE, 2006, 260 (06) : 517 - 529
  • [34] Anti-tumour activity and toxicological studies of combination treatment of Orthosiphon stamineus and gemcitabine on pancreatic xenograft model
    Yehya, Ashwaq Hamid Salem
    Subramaniam, Ayappa, V
    Asif, Muhammad
    Kaur, Gurjeet
    Abdul Majid, Amin M. S.
    Oon, Chern Ein
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (32) : 4620 - 4634
  • [35] Synthesis of 191Pt labelled JM216, an orally active platinum anti-tumour agent
    Univ of Manchester, Manchester, United Kingdom
    Appl Radiat Isot, 4 (469-476):
  • [36] Letter: limitations of studies to evaluate the significance of anti-tumour necrosis factor serum levels in Crohn's disease
    Chaparro, M.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (01) : 120 - 121
  • [37] Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models
    Thomas V. Guy
    Alexandra M. Terry
    Holly A. Bolton
    David G. Hancock
    Elena Shklovskaya
    Barbara Fazekas de St Groth
    Cancer Immunology, Immunotherapy, 2016, 65 : 885 - 896
  • [38] Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models
    Guy, Thomas V.
    Terry, Alexandra M.
    Bolton, Holly A.
    Hancock, David G.
    Shklovskaya, Elena
    Fazekas de St Groth, Barbara
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (08) : 885 - 896
  • [39] ANTI-TUMOUR POTENTIAL OF ACTIVE COMPOUNDS (POLYSACCHARIDES) OF WILD MUSHROOMS FROM RAJOURI DIST. OF JAMMU & KASHMIR, INDIA
    Anand, Nidhi
    Chowdhry, P. N.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (05): : 1743 - 1746
  • [40] Tacrolimus vs anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study
    Yamamoto, T.
    Shimoyama, T.
    Umegae, S.
    Matsumoto, K.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S356 - S356
12345